Initial thoughts: FY21 results and Q1 22 revenue, scandal aftermath
13/05/22 -"The ESG crisis weighed on Orpea’s FY21 results and its occupancy rate in France. The group has signed a sort of “emergency” financing at nearly-doubled costs, showing a worrying liquidity outlook. ..."
Pages
56
Language
English
Published on
13/05/22
You may also be interested by these reports :
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...
30/12/25
Despite revising our estimates and target price downward, DiaSorin remains a compelling investment opportunity. This is underpinned by strong ...
15/12/25
We have revised our estimates upwards to account for enhanced profitability, despite the effects of tariffs and foreign exchange headwinds. This ...